Results indicated that AI-DSS was non-inferior to physician-led adjustments in time in range and insulin dose adjustments, with no diabetes-related adverse events reported in the AI-DSS group (compared to two cases of severe hypoglycemia and one DKA event in the physician group) (13). Here, INS is linked to diabetes mellitus.